FORWARD PHARMA A/S-ADR (FWP)       3.73  -0.24 (-6.05%)

3.73  -0.24 (-6.05%)

US34986J2042 - ADR

FORWARD PHARMA A/S-ADR3.73

NASDAQ:FWP (8/16/2022, 3:30:01 PM)-0.24 (-6.05%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS Sector Health Care
GICS Industry Biotechnology
Chartmill FA Rating
Valuation Growth
Profitability Health
Dividend
Overview
Earnings (Last) 04-14 2022-04-14 Earnings (Next) N/A N/A
Ins Owners N/A Inst Owners 10.64%
Market Cap 26.45M Shares 7.09M
PE N/A Fwd PE N/A
Dividend Yield N/A Analysts 45
IPO 10-15 2014-10-15

Stock Screener Links

Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

FWP Daily chart

Company Profile

Forward Pharma A/S is a biopharmaceutical company, which engages in the research and development of medicinal treatment for inflammatory and neurological indications. The company is developing a proprietary formulation of dimethyl fumarate (DMF), for the treatment of multiple sclerosis (MS) and other inflammatory and neurological indications. DMF is an immunomodulator that can be used as a therapeutic to improve the health of patients with MS and immune disorders .The Company is headquartered in Copenhagen, Denmark.

Company Info

FORWARD PHARMA A/S-ADR

Oestergade 24A, 1, Copenhagen K

COPENHAGEN 1100

P: 4533444242.0

CEO: Claus Bo Svendsen

Employees: 4

Website: http://forward-pharma.com/

News

News Image4 months ago - Forward Pharma A/SForward Pharma Reports Financial and Operating Results for the Year Ended December 31, 2021

COPENHAGEN, Denmark, April 08, 2022 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (“we,” “Forward” or the “Company” and, together with its...

News Imagea year ago - Forward Pharma A/SForward Pharma Announces the Decision of the Technical Board of Appeal of the European Patent Office in the EP2801355 Appeal Hearing

FWP Twits

Here you can normally see the latest stock twits on FWP, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example